Paula Ragan has sold XFOR and made no open-market buys since Mar 2020
President and CEO at X4 Pharmaceuticals, Inc.
SEC CIK 0001769914 · Filings on SEC.gov ↗
$0Bought
$858KSold
NoneLast buy
Every filing
11 filings since Mar 2020, newest first
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$132K−18.0%Oct 8
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$44K−6.0%Mar 11
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$182K−22.0%Nov 3
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$42K−8.0%Mar 13
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$69K−3.0%Aug 19
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$78K−3.0%Jul 16
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$39K−1.0%Jun 2
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$34K−2.0%Dec 28
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$71K−3.0%Sep 10
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$144K−7.0%Jun 3
XFORSell
X4 Pharmaceuticals, Inc
President and CEO
$26K−1.0%Mar 3
Filings come from SEC EDGAR. Not investment advice.